Skip to content
OpenCapital
Get started

Kestra Medical Technologies, Ltd. Common Stock KMTS Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
Cash and cash equivalents
$291.32M+436%$175.42M+128%$201.21M+101%$237.6M+2,780%$54.35M—
Restricted cash
$334K—$334K—$334K—$334K0.0%——
Accounts receivable, net
$12.71M+280%$10.41M+559%$9.25M+220%$8.08M+304%$3.34M+435%
Prepaid expenses and other current assets
$3.2M+748%$2.66M—$3.43M+781%$3.08M+125%$378K+557%
Total current assets
$314.06M—$195.41M—$220.69M—$255.33M+1,613%——
Property and equipment, net
$53.8M—$45.93M—$40.38M—$34.83M+33.4%——
Operating lease right-of-use assets
$3.42M—$1.96M—$2.05M—$2.08M-9.1%——
Other non-current assets
$5.88M—$1.2M—$1.06M—$1.15M+90.0%——
Total assets
$379.34M—$246.7M—$266.3M—$295.74M+544%——
Accounts payable
$24.02M+499%$20.21M+874%$18.57M+720%$23.96M+0.3%$4.01M+119%
Accrued expenses
$18.9M—$15.49M—$13.65M—$13.83M+52.3%——
Operating lease liabilities, current
$10K—$53K—$36K—$187K———
Total current liabilities
$42.93M—$35.76M—$32.26M—$37.98M+15.2%——
Long-term debt
$42.26M—$41.87M—$41.49M—$41.1M-3.4%——
Operating lease liabilities, non-current
$4.28M—$2.87M—$3.07M—$3.03M+14.9%——
Operating Lease Liabilities (Total)
$1.59M—————$3.21M———
Other non-current liabilities
$140K—$140K—$140K—$140K+84.2%——
Total liabilities
$91.35M—$82.62M—$82.14M—$90.34M+15.5%——
Common stock
$58.35M+58,348,900%$51.45M—$51.35M—$51.35M+158%$100—
Additional paid-in capital
$842.67M—$691.49M—$678.89M—$674.31M+281%——
Retained earnings
-$613.03M—-$578.86M—-$546.08M—-$520.25M-28.0%——
Total liabilities and stockholders' equity
$379.34M—$246.7M—$266.3M—$295.74M+544%——
Disposable Medical Equipment Supplies Current
$6.83M—$6.92M—$6.8M—$6.57M+99.8%——
Deferred Tax Assets and Other Non-Current Assets
$5.88M—$1.2M—$1.06M—$1.15M+90.0%——
Deposits on Licenses
$1.85M—$1.86M—$1.79M—$2.02M+18.2%——
Net Investment in Lease
$3.42M—$1.96M—$2.05M—$2.08M-9.1%——
Operating lease right-of-use assets
$3.42M—$1.96M—$2.05M—$2.08M-9.1%——
Other non-current assets
$5.88M—$1.2M—$1.06M—$1.15M+90.0%——
Operating Lease Right-of-Use Assets in Other Assets
$3.42M—$1.96M—$2.05M—$2.08M-9.1%——
Software and Technology Licenses, Net
$5.88M—$1.2M—$1.06M—$1.15M+90.0%——
Other Commercial Liabilities
$18.9M—$15.49M—$13.65M—$13.83M+52.3%——
Accrued Liabilities, Current
$18.9M—$15.49M—$13.65M—$13.83M+52.3%——
Total debt
$43.85M—$44.8M—$44.59M—$44.31M-1.9%——
Additional paid-in capital
$842.67M—$691.49M—$678.89M—$674.31M+281%——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
$58.35M+58,348,900%$51.45M—$51.35M—$51.35M+158%$100—
Warrants And Rights Outstanding
$1.75M—$1.98M—$5.19M—$8.1M———

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Kestra Medical Technologies, Ltd. Common Stock's total assets?
Kestra Medical Technologies, Ltd. Common Stock (KMTS) holds $379.3M in total assets.
How much cash does Kestra Medical Technologies, Ltd. Common Stock have?
Kestra Medical Technologies, Ltd. Common Stock holds $291.3M in cash and equivalents.
Can Kestra Medical Technologies, Ltd. Common Stock cover its short-term obligations?
Its current ratio is 7.32 — current assets exceed current liabilities.
Where does Kestra Medical Technologies, Ltd. Common Stock's balance sheet data come from?
Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.